As the first building on the block, the 7,800 square meters newbuild will be an important cog in the wheel of further development of the area. The building, scheduled for completion in the summer of 2021, will contain premises for research, production and development of analytical methods for cancer diagnostics.

“Excellent collaboration with the client and user has enabled us to optimise construction for completion of the building as early as summer 2021,” says Magnus Andersson of BRA Bygg.

Veidekke’s subsidiary BRA Bygg (Billström Riemer Andersson AB), located in Gothenburg, Sweden, has 285 employees and annual turnover of SEK 2.1 billion.